Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malignant blood diseases. Listen as she covers emerging gene therapies, bispecific antibodies, cancer-associated thrombosis, and practical referral guidance for conditions like ITP, TTP, and sickle cell disease.

Julie Lang, MD, Breast Surgical Oncologist, joins the Cancer Advances podcast to discuss advancing care for patients with inflammatory breast cancer. Listen as Dr. Lang outlines key clinical features that distinguish IBC from infection, evidence-based sequencing of neoadjuvant therapy, surgery and radiation, and highlights emerging tools and translational research efforts aimed at improving outcomes in this aggressive subtype.

Associate Staff and Physician Scientist at Cleveland Clinic Children’s, Richa Sharma, MD, joins the Cancer Advances podcast to discuss the launch of a National DNA Repair and Telomere Biology Disorder Tumor Board. Listen as Dr. Sharma explains the cancer predisposition associated with these rare inherited disorders, the challenges of treating malignancy in patients with impaired DNA repair, and how a multidisciplinary, national tumor board can help clinicians navigate complex treatment decisions and toxicity risks.